[{"Assets_0_Q2_USD":"446906000.0","CIK":"1023024","Country":"United States","EarningsPerShareBasic_1_Q2_USD":"0.55","EarningsPerShareBasic_2_Q2_USD":"0.59","EarningsPerShareDiluted_1_Q2_USD":"0.53","EarningsPerShareDiluted_2_Q2_USD":"0.57","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","Market Cap":"569805985.0","NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":"19035000.0","NetIncomeLossAvailableToCommonStockholdersBasic_1_Q2_USD":"6478000.0","NetIncomeLossAvailableToCommonStockholdersBasic_2_Q2_USD":"6920000.0","NetIncomeLoss_1_Q2_USD":"6585000.0","NetIncomeLoss_2_Q2_USD":"7034000.0","OfficialName":"ANI Pharmaceuticals Inc.","RevenuesConverted_1_Q2_USD":"54357000.0","RevenuesConverted_2_Q2_USD":"107244000.0","SP500":null,"Sector":"Health Care","StockholdersEquity_0_Q2_USD":"207656000.0","Ticker":"ANIP","TreasuryStockSharesConverted_0_Q2_shares":"12311.0","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":"12269000.0","WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":"12046000.0","WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":"11851000.0","WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":"11799000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":"11851000.0","WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":"11799000.0","filed":"20190807","footnote":null,"form":"10-Q","fp":"Q2","fy":"2019.0","name":"ANI PHARMACEUTICALS INC","period":"20190630","qtrs":"0","uom":"USD"}]